6733.TWO · BIOGEND
Taiwan · RS rating 8 · As of 2026-10-08
| Price | 24.90 TWD |
|---|---|
| 1-day change | +0.2% |
| RS rating (overall / 1M / 3M / 12M) | 8 / 15 / 41 / 8 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 23 / 11 / 16 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | -38.5% |
| Sales growth Q/Q | +8.3% |
| Distance from 52-week high | +45.8% |
| Market cap (USD) | $105.6M |